Skip to content

Clinical study on the value of CT quantitative skeletal muscle area and skeletal muscle attenuation in the diagnosis of sarcopenia

CT-based skeletal muscle index and skeletal muscle gauge diagnosis of sarcopenia: a prospective, diagnostic study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053074
Enrollment
Unknown
Registered
2021-11-10
Start date
2021-11-20
Completion date
Unknown
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Gold Standard:According to the consensus of Asian sarcopenia diagnostic experts in 2019: 1.Limb skeletal muscle content: bioelectrical impedance method (male =12s.
Index test:1.CT&#32
quantitative&#32
index&#32
and&#32
gauge.&#32
=&#32
square&#32
of&#32

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Stable condition and normal cognition; 2.Can cooperate to complete questionnaire survey, grip strength test, five sit ups and walk tests.

Exclusion criteria

Exclusion criteria: 1.Acute or aggravated disease; 2.Recent history of surgery; 3.Suffering from any dysfunction affecting limb movement; 4.Deformation of spine or fixation of spine with metal or other materials; 5.Edema, ascites, obesity, electrolyte disorder; 6.There are electronic and metal medical devices such as cardiac pacemaker in the body.

Design outcomes

Primary

MeasureTime frame
Computed tomography scan indicators;Screening guidelines;Muscle volume indicators;Muscle strength indicators;Physical function index;General condition of patients;accuracy, specificity, sensitivity, AUC of ROC;

Countries

China

Contacts

Public ContactXiang Jie

Affiliated Hospital of Xuzhou Medical University

18052268386@163.com+86 13775970412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026